Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adenofort is a metabolic stimulant and nutritional supplement manufactured by Star Laboratories, primarily marketed in Pakistan and surrounding regions. It is formulated as an injectable solution containing a combination of adenosine triphosphate (ATP), cyanocobalamin (Vitamin B12), magnesium aspartate, and potassium aspartate. The product is indicated for the treatment of metabolic disorders, physical exhaustion, muscle fatigue, and convalescence in both human and veterinary medicine. By providing ATP, it offers an immediate source of energy for cellular processes, while Vitamin B12 supports hematopoiesis and neurological function. The aspartate salts serve to replenish essential electrolytes and support the urea cycle, aiding in the reduction of ammonia levels during intense physical activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adenofort.